Table 2.
The clinical characteristics and management of the various prepubertal testicular tumours.
| Pathology | n | Median age (years) | Side | Treatment | Median follow-up (months) |
|---|---|---|---|---|---|
| Germ cell tumours | |||||
| Benign | 0 | ||||
| Malignant | 5 | ||||
| Yolk sac | 3 | 7.5 | Left (2), right (1) | RO | 12 |
| Seminoma | 1 | 13 | Right | RO | 16 |
| Mixed germ-cell tumour | 1 | 8 | Left | RO + chemotherapy | 15 |
| Sex-cord stromal tumour | |||||
| Benign | 4 | ||||
| Leydig cell | 2 | 11 | Right (1), left (1) | RO (1), testicular-sparing (1) | 24 |
| Sertoli cell | 2 | 3.5 | Left | RO | – |
| Malignant | 0 | ||||
| Paratesticular tumours | |||||
| Benign | 1 | ||||
| Haemangioma | 1 | 16 | Right | RO | |
| Malignant | 1 | ||||
| Embryonal | 1 | 10 | Right | RO | 36 |
| Rhabdomyosarcoma | |||||
| Others | |||||
| Macro-orchidism | 1 | 10 | Right | Testicular-sparing | 20 |
| Leydig cell hyperplasia | 1 | 3 | Right | Testicular-sparing | 28 |
RO, radical orchidectomy.